Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nephros (NEPH) EBT (2016 - 2025)

Nephros has reported EBT over the past 16 years, most recently at $62000.0 for Q4 2025.

  • Quarterly results put EBT at $62000.0 for Q4 2025, down 82.97% from a year ago — trailing twelve months through Dec 2025 was $1.2 million (up 1396.34% YoY), and the annual figure for FY2025 was $1.2 million, up 1255.06%.
  • EBT for Q4 2025 was $62000.0 at Nephros, down from $340000.0 in the prior quarter.
  • Over the last five years, EBT for NEPH hit a ceiling of $579000.0 in Q1 2025 and a floor of -$1.6 million in Q1 2022.
  • Median EBT over the past 5 years was -$358500.0 (2023), compared with a mean of -$412700.0.
  • Peak annual rise in EBT hit 428.98% in 2025, while the deepest fall reached 82.97% in 2025.
  • Nephros' EBT stood at -$726000.0 in 2021, then grew by 5.1% to -$689000.0 in 2022, then increased by 9.72% to -$622000.0 in 2023, then soared by 158.52% to $364000.0 in 2024, then plummeted by 82.97% to $62000.0 in 2025.
  • The last three reported values for EBT were $62000.0 (Q4 2025), $340000.0 (Q3 2025), and $246000.0 (Q2 2025) per Business Quant data.